1. Identification of key factors that reduce the variability of the single photon response. Caruso G, Bisegna P, Andreucci D, Lenoci L, Gurevich VV, Hamm HE, DiBenedetto E (2011) Proc Natl Acad Sci U S A 108(19): 7804-7
    › Primary publication · 21518901 (PubMed) · PMC3093507 (PubMed Central)
  2. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation. Seo J, Tsakem EL, Breitman M, Gurevich VV (2011) J Biol Chem 286(32): 27894-901
    › Primary publication · 21715332 (PubMed) · PMC3151035 (PubMed Central)
  3. Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins. Vishnivetskiy SA, Gimenez LE, Francis DJ, Hanson SM, Hubbell WL, Klug CS, Gurevich VV (2011) J Biol Chem 286(27): 24288-99
    › Primary publication · 21471193 (PubMed) · PMC3129209 (PubMed Central)
  4. Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes. Zhan X, Gimenez LE, Gurevich VV, Spiller BW (2011) J Mol Biol 406(3): 467-78
    › Primary publication · 21215759 (PubMed) · PMC3034793 (PubMed Central)
  5. A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding. Coffa S, Breitman M, Spiller BW, Gurevich VV (2011) Biochemistry 50(32): 6951-8
    › Primary publication · 21732673 (PubMed) · PMC3153575 (PubMed Central)
  6. Arrestin-1 expression level in rods: balancing functional performance and photoreceptor health. Song X, Vishnivetskiy SA, Seo J, Chen J, Gurevich EV, Gurevich VV (2011) Neuroscience : 37-49
    › Primary publication · 21075174 (PubMed) · PMC3020241 (PubMed Central)
  7. The role of arrestin alpha-helix I in receptor binding. Vishnivetskiy SA, Francis D, Van Eps N, Kim M, Hanson SM, Klug CS, Hubbell WL, Gurevich VV (2010) J Mol Biol 395(1): 42-54
    › Primary publication · 19883657 (PubMed) · PMC2787876 (PubMed Central)
  8. Non-visual arrestins are constitutively associated with the centrosome and regulate centrosome function. Shankar H, Michal A, Kern RC, Kang DS, Gurevich VV, Benovic JL (2010) J Biol Chem 285(11): 8316-29
    › Primary publication · 20056609 (PubMed) · PMC2832982 (PubMed Central)
  9. Ligand-induced internalization and recycling of the human neuropeptide Y2 receptor is regulated by its carboxyl-terminal tail. Walther C, Nagel S, Gimenez LE, Mörl K, Gurevich VV, Beck-Sickinger AG (2010) J Biol Chem 285(53): 41578-90
    › Primary publication · 20959467 (PubMed) · PMC3009885 (PubMed Central)
  10. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Ahmed MR, Berthet A, Bychkov E, Porras G, Li Q, Bioulac BH, Carl YT, Bloch B, Kook S, Aubert I, Dovero S, Doudnikoff E, Gurevich VV, Gurevich EV, Bezard E (2010) Sci Transl Med 2(28): 28ra28
    › Primary publication · 20410529 (PubMed) · PMC2933751 (PubMed Central)